Suzanne Craft
#119,278
Most Influential Person Now
Suzanne Craft's AcademicInfluence.com Rankings
Suzanne Craftpsychology Degrees
Psychology
#2425
World Rank
#2815
Historical Rank
Neuropsychology
#57
World Rank
#60
Historical Rank
Cognitive Psychology
#213
World Rank
#220
Historical Rank
Suzanne Craftphilosophy Degrees
Philosophy
#5336
World Rank
#8104
Historical Rank
Logic
#2630
World Rank
#3646
Historical Rank
Download Badge
Psychology Philosophy
Suzanne Craft's Degrees
- PhD Psychology University of California, San Diego
- Doctorate Medicine University of California, San Diego
Why Is Suzanne Craft Influential?
(Suggest an Edit or Addition)Suzanne Craft's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease (2011) (5616)
- Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. (2012) (1059)
- Effects of aerobic exercise on mild cognitive impairment: a controlled trial. (2010) (1037)
- Insulin and neurodegenerative disease: shared and specific mechanisms (2004) (779)
- Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums (2018) (710)
- Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease (2006) (656)
- Intranasal insulin improves cognition and modulates β-amyloid in early AD (2008) (632)
- Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup (2011) (624)
- Ketamine-Induced NMDA Receptor Hypofunction as a Model of Memory Impairment and Psychosis (1999) (594)
- Glucose levels and risk of dementia. (2013) (588)
- Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype (2006) (583)
- Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. (2011) (528)
- The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. (2009) (515)
- Vascular contributions to cognitive impairment and dementia including Alzheimer's disease (2015) (478)
- Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. (2008) (476)
- Glucocorticoid-induced impairment in declarative memory performance in adult humans (1994) (467)
- Memory improvement following induced hyperinsulinemia in alzheimer's disease (1996) (457)
- Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. (2014) (455)
- Intranasal insulin improves cognition and modulates beta-amyloid in early AD. (2008) (450)
- Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment. (2007) (445)
- Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. (2005) (439)
- A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease (2015) (434)
- Testosterone supplementation improves spatial and verbal memory in healthy older men (2001) (428)
- Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. (1993) (410)
- Intranasal Insulin as a Treatment for Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence (2013) (408)
- Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease (1998) (404)
- Pathological correlates of dementia in a longitudinal, population‐based sample of aging (2007) (402)
- Effects of β-hydroxybutyrate on cognition in memory-impaired adults (2004) (373)
- Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib. (2008) (372)
- Intracerebroventricular insulin enhances memory in a passive-avoidance task (2000) (342)
- Insulin resistance syndrome and Alzheimer's disease: Age- and obesity-related effects on memory, amyloid, and inflammation (2005) (336)
- Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele. (2003) (328)
- Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose. (1999) (321)
- Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice (2006) (319)
- Extended results of the Alzheimer’s disease anti-inflammatory prevention trial (2011) (317)
- Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease. (2004) (308)
- Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia. (2015) (307)
- Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer’s Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study (2010) (304)
- Diabetic Microvascular Disease: An Endocrine Society Scientific Statement (2017) (295)
- The relationship between neuropsychological functioning and driving ability in dementia: a meta-analysis. (2004) (293)
- High-dose estradiol improves cognition for women with AD (2001) (264)
- Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment (2005) (258)
- Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer’s disease: results of a placebo-controlled, double-blind, pilot study (1999) (257)
- Insulin dose–response effects on memory and plasma amyloid precursor protein in Alzheimer’s disease: interactions with apolipoprotein E genotype (2003) (255)
- The Role of Insulin Resistance in the Pathogenesis of Alzheimer’s Disease (2003) (251)
- Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches (2020) (248)
- Intranasal Treatment of Central Nervous System Dysfunction in Humans (2012) (247)
- Aerobic exercise improves cognition for older adults with glucose intolerance, a risk factor for Alzheimer's disease. (2010) (235)
- Mechanism of Awareness of Hypoglycemia: Perception of Neurogenic (Predominantly Cholinergic) Rather Than Neuroglycopenic Symptoms (1993) (230)
- Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment (2019) (229)
- Contributions of clinical neuropsychology to the study of schizophrenia. (1989) (221)
- Insulin increases CSF Aβ42 levels in normal older adults (2003) (220)
- Different patterns of cerebral injury in dementia with or without diabetes. (2009) (214)
- Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults. (2005) (214)
- Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer’s Disease Biomarkers: A Pilot Clinical Trial (2017) (211)
- The role of aromatization in testosterone supplementation (2005) (208)
- Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. (2004) (206)
- Glucose and memory in mild senile dementia of the Alzheimer type. (1992) (196)
- Effects of hyperglycemia on memory and hormone levels in dementia of the Alzheimer type: a longitudinal study. (1993) (191)
- Insulin resistance predicts brain amyloid deposition in late middle-aged adults (2015) (183)
- Insulin Effects on Glucose Metabolism, Memory, and Plasma Amyloid Precursor Protein in Alzheimer's Disease Differ According to Apolipoprotein‐E Genotype (2000) (182)
- Insulin, cognition, and dementia. (2013) (177)
- Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease. (2013) (173)
- CSF Aβ42 and tau in Parkinson's disease with cognitive impairment (2010) (172)
- Coronary-prone behavior pattern and cardiovascular response. (1978) (169)
- Insulin Resistance Syndrome and Alzheimer Disease: Pathophysiologic Mechanisms and Therapeutic Implications (2006) (166)
- Insulin Resistance and Alzheimer’s Disease: Bioenergetic Linkages (2017) (164)
- Glucose effects on complex memory and nonmemory tasks: The influence of age, sex, and glucoregulatory response (1994) (164)
- Insulin Metabolism in Alzheimer’s Disease Differs According to Apolipoprotein E Genotype and Gender (1999) (160)
- Enhancement of Vasoreactivity and Cognition by Intranasal Insulin in Type 2 Diabetes (2014) (156)
- Brain Insulin Signaling and Alzheimer's Disease: Current Evidence and Future Directions (2011) (150)
- Sex biology contributions to vulnerability to Alzheimer's disease: A think tank convened by the Women's Alzheimer's Research Initiative (2016) (145)
- Cognitive screening examinations for silent cerebral infarcts in sickle cell disease (1998) (144)
- Insulin resistance and pathological brain ageing (2011) (143)
- Diabetes and insulin in regulation of brain cholesterol metabolism. (2010) (142)
- Accelerated decline in apolipoprotein E-ϵ4 homozygotes with Alzheimer's disease (1998) (141)
- Conventional versus intensive diabetes therapy in children with type 1 diabetes: effects on memory and motor speed. (1999) (139)
- Insulin and Alzheimer's disease: untangling the web. (2012) (137)
- Comparative Microbiome Signatures and Short-Chain Fatty Acids in Mouse, Rat, Non-human Primate, and Human Feces (2018) (135)
- Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment. (2011) (133)
- Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial. (2020) (129)
- Salivary cortisol and memory function in human aging (2006) (127)
- Insulin increases CSF Abeta42 levels in normal older adults. (2003) (122)
- Impaired Insulin Sensitivity as Indexed by the HOMA Score Is Associated With Deficits in Verbal Fluency and Temporal Lobe Gray Matter Volume in the Elderly (2012) (115)
- Alzheimer disease: Insulin resistance and AD—extending the translational path (2012) (114)
- Cognitive changes associated with supplementation of testosterone or dihydrotestosterone in mildly hypogonadal men: a preliminary report. (2003) (112)
- Triglycerides cross the blood–brain barrier and induce central leptin and insulin receptor resistance (2017) (111)
- Brief twice-weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in type 1 diabetes mellitus. (1998) (109)
- Characterization of verbal and spatial memory changes from moderate to supraphysiological increases in serum testosterone in healthy older men (2007) (109)
- Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial. (2012) (107)
- Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes. (1998) (101)
- Neuropsychologic effects of stroke in children with sickle cell anemia. (1993) (98)
- Insulin resistance, inflammation, and cognition in Alzheimer's Disease: Lessons for multiple sclerosis (2006) (95)
- Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer’s disease: a pilot study (2019) (94)
- Effects of Chronic Glucocorticoid Administration on Insulin-Degrading Enzyme and Amyloid-Beta Peptide in the Aged Macaque (2005) (92)
- Differential modulation of plasma β-amyloid by insulin in patients with Alzheimer disease (2006) (90)
- Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease. (1998) (89)
- Memory and insulin dependent diabetes mellitus (IDDM): Effects of childhood onset and severe hypoglycemia (1997) (88)
- Glucose-induced increase in memory performance in patients with schizophrenia. (1999) (86)
- Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis. (2020) (86)
- Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial. (2011) (80)
- Effect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: randomized clinical trial. (2013) (79)
- Dyslexic children have abnormal brain lactate response to reading-related language tasks. (1999) (71)
- Review of 'the potential role of arterial stiffness in the pathogenesis of Alzheimer's disease'. (2015) (70)
- Insulin effects on CSF norepinephrine and cognition in Alzheimer's disease (2006) (70)
- Gut mycobiome and its interaction with diet, gut bacteria and alzheimer's disease markers in subjects with mild cognitive impairment: A pilot study (2020) (70)
- Arterial stiffness and dementia pathology (2018) (69)
- Oestrogen replacement therapy may improve memory functioning in the absence of APOE e4 (2004) (67)
- Beneficial effect of a weight-stable, low-fat/low-saturated fat/low-glycaemic index diet to reduce liver fat in older subjects (2012) (64)
- Neuropathology in the adult changes in thought study: a review. (2009) (63)
- Peripheral amyloid-beta levels regulate amyloid-beta clearance from the central nervous system. (2009) (60)
- Cognitive effects of short-term manipulation of serum sex steroids in healthy young men. (2002) (60)
- Long Acting Intranasal Insulin Detemir Improves Cognition for Adults with Mild Cognitive Impairment or Early-Stage Alzheimer's Disease Dementia. (2015) (60)
- Higher Glycemic Thresholds for Symptoms During β-Adrenergic Blockade in IDDM (1991) (58)
- Impact of Recent Antecedent Hypoglycemia on Hypoglycemic Cognitive Dysfunction in Nondiabetic Humans (1996) (58)
- Amyloid beta antagonizes insulin promoted secretion of the amyloid beta protein precursor. (2002) (57)
- Type 2 Diabetes, Cognition, and Dementia in Older Adults: Toward a Precision Health Approach (2016) (57)
- Gut microbiome-Mediterranean diet interactions in improving host health (2019) (55)
- Session III: Mechanisms of age-related cognitive change and targets for intervention: inflammatory, oxidative, and metabolic processes. (2012) (55)
- Relationship between testosterone supplementation and insulin-like growth factor-I levels and cognition in healthy older men (2004) (54)
- Age- and dose-dependent glucose-induced increases in memory and attention in schizophrenia (1999) (54)
- Visual attention in preschool children prenatally exposed to cocaine: Implications for behavioral regulation (2002) (53)
- Neuropsychologic Deficits in Children with Sickle Cell Disease and Cerebral Infarction: Role of Lesion Site and Volume (1999) (53)
- A nonhuman primate model of early Alzheimer’s disease pathologic change: Implications for disease pathogenesis (2018) (52)
- Visual attention in children with prenatal cocaine exposure (1997) (51)
- Muscle heat shock protein 70 predicts insulin resistance with aging. (2015) (50)
- The role of insulin in the vascular contributions to age-related dementia. (2016) (50)
- Blood-Based Bioenergetic Profiling Reflects Differences in Brain Bioenergetics and Metabolism (2017) (45)
- Changes in cognitive performance in children with spastic diplegic cerebral palsy following selective dorsal rhizotomy. (1995) (44)
- The APOE genotype: modification of therapeutic responses in Alzheimer's disease. (2014) (44)
- The effect of insulin and glucose on the plasma concentration of Alzheimer's amyloid precursor protein (1999) (44)
- Neuropathologic correlates of cognition in a population-based sample. (2013) (43)
- Vitamin E and memantine in Alzheimer's disease: Clinical trial methods and baseline data (2014) (42)
- Early risk assessment for Alzheimer's disease (2009) (42)
- Impact of Type 2 Diabetes and Postmenopausal Hormone Therapy on Incidence of Cognitive Impairment in Older Women (2015) (41)
- Short-term and long-term memory in early temporal lobe dysfunction. (1998) (40)
- Apolipoprotein C-I is an APOE genotype-dependent suppressor of glial activation (2012) (39)
- Effects of a Group Exercise Program on Risk Factors for Falls in Frail Older Adults (1994) (39)
- Extracellular Vesicle Biomarkers Track Cognitive Changes Following Intranasal Insulin in Alzheimer's Disease. (2019) (39)
- High-intensity physical activity modulates diet effects on cerebrospinal amyloid-β levels in normal aging and mild cognitive impairment. (2012) (38)
- Glucocorticoid interactions with memory function in schizophrenia (1998) (38)
- Lateralized deficits in visual attention in males with developmental dopamine depletion (1992) (38)
- Oestrogen replacement therapy may improve memory functioning in the absence of APOE epsilon4. (2004) (37)
- Interhemispheric transfer in children with early-treated phenylketonuria. (1994) (37)
- Growth hormone-releasing hormone effects on brain γ-aminobutyric acid levels in mild cognitive impairment and healthy aging. (2013) (36)
- Montreal Cognitive Assessment and Modified Mini Mental State Examination in African Americans (2015) (33)
- Differential Effects of Meal Challenges on Cognition, Metabolism, and Biomarkers for Apolipoprotein E ɛ4 Carriers and Adults with Mild Cognitive Impairment. (2015) (33)
- Inhibition of return in children with perinatal brain injury (2001) (33)
- Asymmetries in visual-spatial processing following childhood stroke. (2004) (33)
- Insulin resistance and cognitive impairment: a view through the prism of epidemiology. (2005) (33)
- Working Memory and Articulation Rate in Children With Spastic Diplegic Cerebral Palsy (1994) (32)
- Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies: A convening of the Alzheimer's Association & Alzheimer's Drug Discovery Foundation (2017) (31)
- The effects of bifrontal stroke during childhood on visual attention: Evidence from children with sickle cell anemia (1994) (31)
- Test-retest resting-state fMRI in healthy elderly persons with a family history of Alzheimer’s disease (2015) (30)
- Higher glycemic thresholds for symptoms during beta-adrenergic blockade in IDDM. (1991) (29)
- 17β-Estradiol Reduces Plasma Aβ40 for HRT-Naïve Postmenopausal Women With Alzheimer Disease: A Preliminary Study (2003) (29)
- Effects of varying diagnostic criteria on prevalence of mild cognitive impairment in a community based sample. (2011) (28)
- Senolytic Therapy to Modulate the Progression of Alzheimer’s Disease (SToMP-AD): A Pilot Clinical Trial (2021) (28)
- Postmenopausal hormone therapy, type 2 diabetes mellitus, and brain volumes (2015) (26)
- The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial (2018) (26)
- The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial (2018) (26)
- Visual Attention in Children with Perinatal Brain Injury: Asymmetric Effects of Bilateral Lesions (1994) (25)
- Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical Trial. (2021) (24)
- Effects of insulin and octreotide on memory and growth hormone in Alzheimer's disease. (2009) (24)
- Cognitive response to estradiol in postmenopausal women is modified by high cortisol (2012) (23)
- Intranasal Insulin Reduces White Matter Hyperintensity Progression in Association with Improvements in Cognition and CSF Biomarker Profiles in Mild Cognitive Impairment and Alzheimer’s Disease (2021) (23)
- Effects of exercise and nutrition on memory in Japanese Americans with impaired glucose tolerance. (2006) (22)
- Effects of rosiglitazone as monotherapy in APOE4-stratified subjects with mild-to-moderate Alzheimer's disease (2009) (22)
- Short-Term and Long-Term Memory in Early Temporal Lobe Dysfunction (1998) (20)
- Callosal dysfunction in schizophrenia and schizo-affective disorder. (1987) (20)
- Diabetes, Insulin and Alzheimer's Disease (2010) (19)
- The TOMMORROW study: Design of an Alzheimer's disease delay-of-onset clinical trial (2019) (19)
- Associative learning in children with perinatal brain injury (1997) (18)
- Working memory following improvements in articulation rate in children with cerebral palsy (1995) (18)
- The association of circulating amylin with β‐amyloid in familial Alzheimer's disease (2021) (17)
- Cerebrospinal fluid lipidomics: effects of an intravenous triglyceride infusion and apoE status (2019) (17)
- Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status (2021) (16)
- Radiolabeling and initial biological evaluation of [18F]KBM-1 for imaging RAR-α receptors in neuroblastoma. (2017) (15)
- Expanded Demographic Norms for Version 3 of the Alzheimer Disease Centers’ Neuropsychological Test Battery in the Uniform Data Set (2020) (15)
- Changes in metabolic risk factors over 10 years and their associations with late-life cognitive performance: The Multi-Ethnic Study of Atherosclerosis (2017) (13)
- Relationship Between Cerebrovascular Reactivity and Cognition Among People With Risk of Cognitive Decline (2020) (13)
- Steroid-induced elevation of glucose in Alzheimer’s disease: relationship to gender, apolipoprotein E genotype and cognition (2003) (13)
- Apolipoprotein E Genotype and Sex Influence Glucose Tolerance in Older Adults: A Cross-Sectional Study (2016) (13)
- Mediterranean and Western diet effects on Alzheimer's disease biomarkers, cerebral perfusion, and cognition in mid‐life: A randomized trial (2021) (12)
- Nutrition state of science and dementia prevention: recommendations of the Nutrition for Dementia Prevention Working Group (2022) (12)
- Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study (2021) (12)
- A Lesion Analysis of Visual Orienting Performance in Children With Cerebral Vascular Injury (2000) (12)
- A randomized, placebo-controlled trial of intranasal insulin in amnestic MCI and early Alzheimer's (2010) (11)
- Human Striatal Dopaminergic and Regional Serotonergic Synaptic Degeneration with Lewy Body Disease and Inheritance of APOE ε4. (2017) (10)
- Intranasal insulin modulates cerebrospinal fluid markers of neuroinflammation in mild cognitive impairment and Alzheimer’s disease: a randomized trial (2022) (10)
- A geroscience motivated approach to treat Alzheimer’s disease: Senolytics move to clinical trials (2021) (9)
- PET Imaging of [11C]MPC-6827, a Microtubule-Based Radiotracer in Non-Human Primate Brains (2020) (9)
- Using Varying Diagnostic Criteria to Examine Mild Cognitive Impairment Prevalence and Predict Dementia Incidence in a Community-Based Sample. (2019) (9)
- Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer’s disease (2021) (9)
- Secondary endpoint and responder analyses in a study of rosiglitazone XR in APOE4-stratified subjects with mild-to-moderate Alzheimer's disease (2009) (9)
- Associations among vascular risk factors, neuroimaging biomarkers, and cognition: Preliminary analyses from the Multi‐Ethnic Study of Atherosclerosis (MESA) (2021) (8)
- Association Between Physical Performance and Cognitive Function in Older Adults Across Multiple Studies: A Pooled Analysis Study (2020) (8)
- Associations between Markers of Glucose and Insulin Function and Cognitive Function in Healthy African American Elders. (2015) (8)
- Aging‐related Alzheimer's disease‐like neuropathology and functional decline in captive vervet monkeys (Chlorocebus aethiops sabaeus) (2021) (8)
- Therapeutic effects of long-acting intranasal insulin detemir for Alzheimer's dementia or mild cognitive impairment (2013) (8)
- Peripheral Amyloid-β Levels Regulate Amyloid-β Clearance from the Central Nervous System (2011) (8)
- Dissemination Strategies: The Evolution of Learning Resources on the Evaluation of Delirium, Dementia, and Depression (2011) (8)
- Single-synapse analyses of Alzheimer’s disease implicate pathologic tau, DJ1, CD47, and ApoE (2021) (8)
- National Institute on Aging /Alzheimer's Association criteria for Mild Cognitive Impairment applied to chemotherapy treated breast cancer survivors. (2017) (8)
- Androgens and Cognition (2003) (8)
- The Role of Insulin Dysregulation in Aging and Alzheimer’s Disease (2010) (8)
- Statin users without an APOE-epsilon4 allele have increased insulin resistance. (2010) (7)
- Modi fi ed Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in associationwith Alzheimer ' s diseasemarkers in subjects with mild cognitive impairment (2019) (7)
- Isoform-specific dysregulation of AMP-activated protein kinase signaling in a non-human primate model of Alzheimer's disease (2021) (7)
- MEASURING APATHY IN ALZHEIMER'S DISEASE IN THE APATHY IN DEMENTIA METHYLPHENIDATE TRIAL 2 (ADMET 2): A COMPARISON OF INSTRUMENTS (2017) (7)
- Heterogeneity in association between cognitive function and gait speed among older adults: An integrative data analysis study. (2020) (7)
- Insulin and sex interactions in older adults with mild cognitive impairment. (2012) (7)
- Decreased Levels of Blood AMPKα1 but not AMPKα2 Isoform in Patients with Mild Cognitive Impairment and Alzheimer's Disease: A Pilot Study. (2020) (7)
- 17beta-estradiol reduces plasma Abeta40 for HRT-naïve postmenopausal women with Alzheimer disease: a preliminary study. (2003) (7)
- A predictive model using the mesoscopic architecture of the living brain to detect Alzheimer’s disease (2022) (7)
- Synthesis and Initial In Vivo Evaluations of [ 11 C]WX‐132‐18B, a Microtubule PET Imaging Agent (2020) (6)
- Effect of ethanol and cocaine on [11C]MPC-6827 uptake in SH-SY5Y cells (2021) (6)
- Aerobic exercise effects on cognition in at-risk adults: Role of insulin sensitivity and APOE-ε4 (2013) (6)
- Diet, psychosocial stress, and Alzheimer's disease–related neuroanatomy in female nonhuman primates (2020) (6)
- O4-05-05 Rosiglitazone preserves cognitive functions in patients with early Alzheimer's disease (2004) (5)
- THERAPEUTIC EFFECTS OF INTRANASAL INSULIN AND INSULIN ANALOGUES ON COGNITION AND MRI MEASURES IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE (2014) (5)
- P3-012 Effects of rosiglitazone treatment on serum amyloid-beta 1–40 and 1–42 in patients with early Alzheimer's disease (2004) (5)
- Individuals with Alzheimer's disease exhibit a high prevalence of undiagnosed impaired glucose tolerance and type 2 diabetes mellitus (2013) (5)
- KETOGENIC DIET EFFECTS ON BRAIN KETONE METABOLISM AND ALZHEIMER'S DISEASE CSF BIOMARKERS (2016) (5)
- Vascular and microstructural markers of cognitive pathology (2022) (5)
- Is diabetes associated with increased pathological burden in Alzheimer's disease? (2021) (5)
- Aerobic exercise reduces phosphorylated tau protein in cerebrospinal fluid in older adults with mild cognitive impairment (2015) (5)
- Insulin Resistance and Alzheimer’s Disease: A Novel Therapeutic Target (2006) (5)
- Challenges in international clinical trials to delay early symptomatic Alzheimer's disease (2013) (5)
- Automated synthesis of 1-[11C]acetoacetate on a TRASIS AIO module. (2017) (4)
- Temporal emergence of age-associated changes in cognitive and physical function in vervets (Chlorocebus aethiops sabaeus) (2020) (4)
- Long-acting intranasal insulin detemir improves working memory for adults with mild cognitive impairment or early-stage Alzheimer's dementia (2013) (4)
- Insulin Resistance Alzheimer's Disease: Pathophysiology and Treatment (2008) (4)
- Diet, psychosocial stress, and Alzheimer’s disease-related neuroanatomy in female nonhuman primates (2020) (3)
- Insulin, diabetes mellitus, Alzheimer's disease, and apolipoprotein E (1998) (3)
- [11C]MPC‐6827, a microtubule‐based PET imaging tracer: A potential early imaging biomarker for AD and other ADRDs (2020) (3)
- COGNITIVE EFFECTS OF EXOGENOUS TESTOSTERONE ADMINISTRATION IN EUGONADAL AND HYPOGO-NADAL MEN (1988) (3)
- Preliminary mechanistic insights of a brain-penetrant microtubule imaging PET ligand in a tau-knockout mouse model (2022) (3)
- Impaired Insulin Sensitivity as Indexed by the HOMA Score Is Associated With De fi cits in Verbal Fluency and Temporal Lobe Gray Matter Volume in Elderly Men and Women (2012) (3)
- Resveratrol is safe and well-tolerated in individuals with mild-moderate dementia due to Alzheimer’s disease. (S33.009) (2015) (3)
- Association of Vascular Risk Scores and Cognitive Performance in a Diverse Cohort: The Multi-Ethnic Study of Atherosclerosis. (2021) (3)
- Effects of insulin on cerebrospinal fluid levels of Aβ42 (2000) (3)
- Safety and tolerability of rosiglitazone XR in a randomised, placebo-controlled study in APOE4-stratified subjects with mild-to-moderate Alzheimer's disease (2009) (2)
- Cerebrospinal Fluid and Blood-Based Biomarkers in Alzheimer’s Disease and Type 2 Diabetes Spectrum Disorders (2018) (2)
- HIGH INTENSITY AEROBIC EXERCISE IMPROVES PERFORMANCE ON COMPUTER TESTS OF EXECUTIVE FUNCTION IN ADULTS WITH MILD COGNITIVE IMPAIRMENT: IMPLICATIONS FOR COGNITIVE ASSESSMENT IN CLINICAL TRIALS (2016) (2)
- Statin Users Without an APOE- ε 4 Allele have Increased Insulin Resistance (2011) (2)
- Progress in Neurotherapeutics and Neuropsychopharmacology: Insulin Resistance Alzheimer's Disease: Pathophysiology and Treatment (2008) (2)
- Small extracellular vesicles in plasma reveal molecular effects of modified Mediterranean-ketogenic diet in participants with mild cognitive impairment (2022) (2)
- Early Alzheimer's disease‐like reductions in gray matter and cognitive function with aging in nonhuman primates (2022) (2)
- CHANGES IN ADIPOSITY AND CSF BIOMARKERS FOLLOWING A MODIFIED MEDITERRANEAN KETOGENIC DIET (2019) (2)
- Gender differences in cognitive benefits of intranasal insulin (2011) (2)
- Intranasal insulin treatment response in Alzheimer's disease influenced by glucose-stimulated insulin secretion (2012) (2)
- EFFECTS OF AEROBIC EXERCISE ON FUNCTIONAL CONNECTIVITY OF PREFRONTAL CORTEX IN MCI: RESULTS OF A RANDOMIZED CONTROLLED TRIAL (2017) (2)
- Conversion between the Modified Mini‐Mental State Examination (3MSE) and the Mini‐Mental State Examination (MMSE) (2021) (2)
- Lateralized deficits in visual attention in early treated pku (1990) (2)
- Early detection of cognitive decline in high functioning older adults (2000) (2)
- The Impact of High Saturated Fat and High Glycemic Index Foods on Cognitive Function and Alzheimer’s Disease Biomarkers: Does a Typical Western Diet Cause Alzheimer’s Disease? (2015) (2)
- Blood‐based bioenergetic profiling reveals differences in mitochondrial function associated with cognitive performance and Alzheimer's disease (2022) (2)
- Depression symptoms associated with cognitive impairment: Is it really depression? (2000) (2)
- Diet Effects on Cerebrospinal Fluid Amino Acids Levels in Adults with Normal Cognition and Mild Cognitive Impairment (2021) (2)
- O2-02-06 Insulin effects on plasma beta-amyloid levels in normal adults and patients with AD (2004) (2)
- Eye dominance and ct measures of occipital length and width (1990) (2)
- The ketogenic diet as a potential prevention or therapeutic strategy for AD (2020) (2)
- P1-056 Hyperinsulinemia predicts cognitive performance for normal older adults and for patients with Alzheimer's disease (2004) (2)
- OPEN LABEL EXTENSION RESULTS FROM A PHASE II/III TRIAL OF INTRANASAL INSULIN (2019) (2)
- Mild cognitive impairment (MCI) in chemotherapy-treated breast cancer survivors. (2015) (1)
- Changes in Adiposity and Cerebrospinal Fluid Biomarkers Following a Modified Mediterranean Ketogenic Diet in Older Adults at Risk for Alzheimer’s Disease (2022) (1)
- The Role of Insulin Resistance in Age-Related Cognitive Decline and Dementia (2009) (1)
- DIET-RELATED ALTERATIONS IN WHITE MATTER MICROSTRUCTURE IN PARTICIPANTS AT RISK FOR AD (2019) (1)
- P1-255 Cortisol infusion attenuates insulin's facilitation of verbal memory in patients with Alzheimer's disease (2004) (1)
- High-intensity physical activity modulates diet-induced changes in CSF Aβ42 (2011) (1)
- Natural cubic splines for the analysis of Alzheimer's clinical trials. (2022) (1)
- Apolipoprotein C-I is an APOE genotype-dependent suppressor of glial activation (2012) (1)
- Raloxifene: Cognitive-enhancing effects for postmenopausal women with AD (2000) (1)
- Hypertensive Aspects of Cardiometabolic Disorders Are Associated with Lower Brain Microstructure, Perfusion, and Cognition. (2022) (1)
- [11C]MPC‐6827: A microtubule‐based pet imaging tracer for AD and related dementias (2020) (1)
- Insulin resistance and Alzheimer's disease: Untangling the web (2009) (1)
- Six months of controlled aerobic exercise reduces cortisol for women but not men with MCI (2009) (1)
- THE EFFECTS OF DIET INTERVENTION ON METABOLIC HEALTH AND CEREBRAL SPINAL FLUID ALZHEIMER’S DISEASE BIOMARKERS: A RANDOMIZED TRIAL (2018) (1)
- Plasma glycocholic acid and linoleic acid identified as potential mediators of mitochondrial bioenergetics in Alzheimer’s dementia (2022) (1)
- WESTERN AND MEDITERRANEAN DIETS’ EFFECTS ON FOOD CONSUMPTION, ADIPOSITY, CARBOHYDRATE METABOLISM, AND CSF MARKERS OF BRAIN HEALTH IN FEMALE CYNOMOLGUS MACAQUES (MACACA FASCICULARIS) (2018) (1)
- A novel approach to isolate brain‐cell–derived exosomes from plasma to better understand pathogenesis of Alzheimer’s disease (2020) (1)
- A DIET HIGH IN SATURATED FAT AND SIMPLE CARBOHYDRATES REDUCES CEREBRAL PERFUSION AND INCREASES LEVELS OF CEREBROSPINAL FLUID AB42: A RANDOMIZED TRIAL (2018) (1)
- Initial biological evaluation of a novel microtubule‐based PET ligand in rodent and NHP models of AD (2021) (1)
- Difference in allostatic interoceptive network connectivity by cognitive status (2021) (1)
- Insulin degrading enzyme expression is reduced in hippocampus of Alzheimer's disease patients (2000) (1)
- DUAL-TRACER ACETOACETATE AND GLUCOSE METABOLISM ARE ASSOCIATED WITH NEUROPATHOLOGIC AMYLOID BURDEN AND ALZHEIMER’S BIOMARKERS IN THE CSF (2016) (1)
- Review Article Vascular contributions to cognitive impairment and dementia including Alzheimer's disease (2014) (1)
- Increased declarative memory performance during controlled hyperglycemia in patients with schizophrenia (1995) (1)
- Metabolic status and family history as determinants of Alzheimer’s risk using diffusion tensor imaging (2015) (1)
- A NON-HUMAN PRIMATE MODEL OF EARLY ALZHEIMER’S DISEASE PATHOLOGIC CHANGE (2018) (1)
- Insulin and cortisol effects of memory in Alzheimer's disease (2000) (1)
- Testosterone (T) administration improves spatial and verbal memory in normal men (1996) (1)
- Heterogeneity of MCI characterization across two time points in a community-based population (2010) (1)
- Insulin and Alzheimer disease-reply. (2012) (1)
- Cognitive status, brain amyloid pathology, and neurodegeneration are associated with altered white matter microstructure (2020) (1)
- Care Management to Promote Treatment Adherence in Patients with Cognitive Impairment and Vascular Risk Factors: A Demonstration Project (2017) (1)
- P2-020 Liver-mediated clearance of peripheral amyloid-beta (1-40) (2006) (1)
- AGING-RELATED MITOCHONDRIAL DYSFUNCTION AND COGNITIVE FUNCTION: A TRANSCRIPTOMIC ANALYSIS OF MONOCYTES IN A COMMUNITY-BASED POPULATION (2017) (1)
- Brain region specific disruption of mitochondrial bioenergetics in cynomolgus macaques fed a Western vs. a Mediterranean diet. (2021) (1)
- Racial differences in dementia‐related pathology underlying cognitive decline: The Multi‐Ethnic Study of Atherosclerosis (MESA) (2021) (1)
- CHANGES IN METABOLIC RISK FACTORS OVER 10 YEARS AND THEIR ASSOCIATIONS WITH COGNITIVE PERFORMANCE: THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) (2016) (1)
- DIET-RELATED ALTERATIONS IN WHITE MATTER MICROSTRUCTURE IN PARTICIPANTS AT RISK FOR AD (2019) (1)
- IN VIVO EVALUATIONS OF MICROTUBULE-BASED PET RADIOTRACER, [11C]MPC-6827 IN MURINE MODELS OF ALZHEIMER'S DISEASE (2019) (1)
- Prevalence of MCI in a community-based population (2009) (1)
- Racial‐ethnic differences in baseline and longitudinal change in neuropsychological test scores in the NACC Uniform Data Set 3.0 (2021) (1)
- Effects of a Ketogenic and Low Fat Diet on the Human Metabolome, Microbiome and Food-ome in Adults at Risk for Alzheimer's Disease (2022) (1)
- Oral glucose tolerance testing to modulate plasma amyloid levels: A novel biomarker (2015) (1)
- O3-05-05 Therapeutic effects of daily intranasal insulin administration in early Alzheimer’s disease (2006) (1)
- Elevated diastolic blood pressure predicts poorer verbal memory in MCI adults with prediabetes (2012) (0)
- Higher arterial stiffness and systolic blood pressure are differentially associated with lower perfusion in subcortical and cortical gray matter regions (2022) (0)
- #620 Cognitive screening examination for silent cerebral infarcts in sickle cell anemia (1998) (0)
- Dementia and type 2 diabetes: The role of body composition and insulin degrading enzyme (2010) (0)
- Automated Synthesis of [11C]acetoacetate on a commercially available synthesizer with non-human pirmate PET brain imaging (2016) (0)
- Co-Occurrence of Physical and Cognitive Decline in Vervet Monkeys (Chlorocebus aethiops sabaeus) (2020) (0)
- Prediction of neuropathologic lesions from clinical data. (2023) (0)
- Workshop on hypoglycemia and the brain (2001) (0)
- Investigating neuroimaging differences by cognitive and metabolic status in a community‐dwelling cohort (2020) (0)
- Brain Resilience: The Effect of White Matter Disease on Brain Networks in Cognitively Normal Older Adults (2020) (0)
- DISEASE SUBJECTS WITH PRESENILIN 1 MUTATIONS (0)
- Impaired glucose tolerance in Mild Cognitive Impairment is associated with lower brain amyloid on PET (2022) (0)
- COMBINING STRUCTURAL MRI, PROTEOMIC, AND GENETIC ADNI DATA FOR EARLY DETECTION OF ALZHEIMER'S DISEASE VIA RANDOM FOREST CLASSIFIERS (2014) (0)
- Blood based bioenergetic profiling reports on muscle mitochondrial function and is responsive to dietary intervention (2016) (0)
- P-165 Hypertensive APOE-e4 carriers at greater risk of cognitive decline? (2007) (0)
- Comparison of actuarial and conventional MCI criteria in a community‐based prospective cohort study: The Adult Changes in Thought (ACT) study (2021) (0)
- APOE GENOTYPE INFLUENCES BRAIN TO BLOOD GLUCOSE RATIOS AFTER HIGH FAT FEEDING (2018) (0)
- ANTECEDENT VASCULAR RISK SCORES AND COGNITIVE FUNCTION AND DECLINE: THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (2018) (0)
- ARTERIAL STIFFNESS IS ASSOCIATED WITH GREATER WHITE MATTER BLOOD FLOW AND WHITE MATTER HYPERINTENSITIES REGARDLESS OF COGNITIVE STATUS (2019) (0)
- APOE genotype and gender influence glucose tolerance in older adults with cognitive impairment (2013) (0)
- Intranasal insulin modulates cerebrospinal fluid markers of neuroinflammation in mild cognitive impairment and Alzheimer’s disease: a randomized trial (2022) (0)
- S3-02-04 PPARγ agonists: Novel therapeutic agents for AD (2007) (0)
- P-151 Co-administration of estradiol and cortisol modulates beta-amyloid, IGF activity, and cognitive function for older postmenopausal women (2007) (0)
- Heart failure with preserved ejection fraction (HFpEF) is associated with cognitive impairment and reduced brain volume (2020) (0)
- Transcriptional profiles in olfactory pathway–associated brain regions of African green monkeys: Associations with age and Alzheimer's disease neuropathology (2022) (0)
- P4-341 Effects of insulin and octreotide on memory in Alzheimer’s disease and healthy aging (2006) (0)
- In vivo biomarkers of arteriolosclerosis are associated with ADRD biomarkers (2022) (0)
- Assessing the Clinical Meaningfulness of the Alzheimer’s Disease Composite Score (ADCOMS) Tool (2022) (0)
- Effects of Alzheimer’s Disease Risk Factors on Cerebrovascular Dynamics in Gray Matter (2022) (0)
- Examining a Preclinical Alzheimer’s Cognitive Composite for Telehealth Administration, the tPACC, for Reliability between In-Person and Remote Cognitive Testing (P6-6.002) (2023) (0)
- EFFECTS OF AEROBIC EXERCISE ON COGNITION AND BIOMARKERS IN ADULTS WITH A DOUBLE-HIT RISK FOR DEMENTIA: MILD COGNITIVE IMPAIRMENT AND PREDIABETES (2014) (0)
- 1561-P: Associations between ß-Cell Function and Cognitive Measures Differ in Youth vs. Adults with Impaired Glucose Tolerance (IGT) or Early Type 2 Diabetes (T2D) (2019) (0)
- OR03-4 Five months treatment with a long-acting GHRH analog improves cognition in healthy older men and women and in patients with mild cognitive impairment (2012) (0)
- Ab immunotherapy results in down-regulation of microglial activation and potentially reduces the inflammation-mediated component of neurode- generation of AD. P1-345 CONSEQUENCES OF BETA-AMYLOID IMMUNOTHERAPY FOR ALZHEIMER’S DISEASE ON NEURONS IN THE HUMAN CEREBRAL CORTEX (2013) (0)
- VASCULAR RISK FACTORS AND MULTIMODAL NEUROIMAGING BIOMARKERS: PRELIMINARY ANALYSES FROM THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) (2019) (0)
- MULTI-SCALE ANALYSIS OF WHITE MATTER DEGENERATION IN COGNITIVELY NORMAL AND MCI ADULTS. (2019) (0)
- P1-425 Raloxifene enhances cognitive function for postmenopausal women with Alzheimer's disease (2004) (0)
- Assessing the effect of modified Mediterranean‐ketogenic diet on mild cognitive impairment patients through plasma neuron‐derived exosomes (2021) (0)
- P-036 Differential modulation of plasma beta-amyloid during an oral glucose tolerance test in normal and MCI subjects (2007) (0)
- Insulin and Alzheimer's disease (2012) (0)
- Interactions of diabetes and postmenopausal hormone therapy on brain volumes: Whims (2015) (0)
- MicroRNA expression in extracellular vesicles as a novel blood-based biomarker for Alzheimer's disease. (2023) (0)
- VASCULAR RISK FACTORS AND MULTIMODAL NEUROIMAGING BIOMARKERS: PRELIMINARY ANALYSES FROM THE MULTIETHNIC STUDY OF ATHEROSCLEROSIS (MESA) (2019) (0)
- Heterogeneity of response to methylphenidate in apathetic patients in the ADMET 2 Trial (2022) (0)
- P2-188 Prediction of cognitive impairment among elderly persons using a brief cognitive screening battery (2006) (0)
- Vascular and microstructural markers of cognitive pathology (0)
- Mediterranean versus Western diet effects on cerebral cortical thickness and volume in cynomolgus monkeys (2020) (0)
- Regional cerebrovascular reactivity and cognitive performance among people with risk of cognitive decline (2021) (0)
- Cerebral insulin receptors: a nexus for vascular and metabolic contributions to Alzheimer's disease. (2022) (0)
- Initial biological evaluations of a novel microtubule‐based PET ligand in Alzheimer’s disease (2021) (0)
- Ketogenic dietary lifestyle intervention effects on sleep, cognition, and behavior in mild cognitive impairment: Study design (2022) (0)
- Growth Hormone – Releasing Hormone Effects on Brain γ-Aminobutyric Acid Levels inMild Cognitive Impairment and Healthy Aging (2013) (0)
- APOE E4 ALLELE EFFECT ON VASCULAR REACTIVITY MEASURED BY BREATH-HOLD ARTERIAL SPIN LABELING IN NORMAL AND MEMORY-IMPAIRED ADULTS (2016) (0)
- Higher arterial stiffness and systolic blood pressure are differentially associated with lower perfusion in subcortical and cortical gray matter regions (2022) (0)
- P2-224 Regional overlap of cerebral glucose metabolism at rest and during list learning for older insulin resistant and Alzheimer adults (2006) (0)
- Type 2 diabetes and recurrent hypoglycemia both elevate hippocampal amyloid, but by different mechanisms (2010) (0)
- Cardiometabolic disorders are associated with reduced cerebral perfusion and white matter microstructure (2021) (0)
- Modified Mediterranean ketogenic diet resolves default mode network connectivity differences between adults with normal and impaired cognition (2021) (0)
- Perceived Stress and Loneliness During the COVID‐19 Pandemic in a Cognitive Aging Cohort (2022) (0)
- Adiposity Is Positively Associated With AD-Signature Cortical Thickness in Older Adults (2020) (0)
- LONGITUDINAL ANALYSIS OF MICROSTRUCTURAL WHITE MATTER CHANGE IN MCI FOLLOWING A 6-MONTH AEROBIC EXERCISE INTERVENTION (2018) (0)
- In vivo biomarkers of arteriolosclerosis are associated with ADRD biomarkers (2022) (0)
- Mild cognitive impairment: Classification methods and two-year dementia conversion rates (2012) (0)
- USING MULTIMODAL IMAGING BIOMARKERS TO PREDICT COGNITIVE STATUS IN A COMMUNITY-DWELLING OLDER ADULT COHORT (2018) (0)
- Effects of diet and social status on white matter integrity in female cynomolgus monkeys (2021) (0)
- Correction to: Temporal emergence of age-associated changes in cognitive and physical function in vervets (Chlorocebus aethiops sabaeus) (2021) (0)
- P-206 Pioglitazone modulates plasma levels of β-amyloid in glucose intolerant older adults (2007) (0)
- USING MULTIMODAL IMAGING BIOMARKERS TO PREDICT COGNITIVE STATUS IN A COMMUNITY-DWELLING OLDER ADULT COHORT (2018) (0)
- MATTER MICROSTRUCTURE IN PARTICIPANTS AT RISK FOR AD P3-401 DIET-RELATED ALTERATIONS IN WHITE (2019) (0)
- INVESTIGATING THE IMPACTS OF DIABETIC STATUS AND COGNITIVE DIAGNOSIS ON AD SIGNATURE CORTICAL THICKNESS (2018) (0)
- Cerebral Perfusion and Cortical Thickness Predict Cognitive Impairment in a Community‐dwelling Cohort (2022) (0)
- P2-192 Episodic memory profile for amnestic mild cognitive impairment (2006) (0)
- BIOMECHANICAL CHARACTERIZATION OF BRAIN ATROPHY IN COGNITIVELY NORMAL AND MCI GROUPS (2017) (0)
- Agraphic Changes In Mild Cognitive Impairment (2004) (0)
- Preliminary biological evaluations of first brain‐penetrant GPR119‐based radiotracer in rodents and non‐human primates (2022) (0)
- Diet and Stress Impair Ovarian Function in Mid-life, Increasing Risk of Chronic Diseases of Aging in Primates (2021) (0)
- Associations between amyloid‐β, white matter disease, functional brain networks, and mobility function: Possible indicators of reserve and resilience (2020) (0)
- ARTERIAL STIFFNESS IS ASSOCIATED WITH INCREASED RISK OF INCIDENT DEMENTIAINTHEOLDERELDERLY: THE CARDIOVASCULAR HEALTH STUDY AND THE MULTI-ETHNIC OF ATHEROSCLEROSIS (2018) (0)
- P3-038 High plasma insulin levels provoke increases in central but not peripheral cytokine levels: relationship to CSF and plasma beta amyloid (2004) (0)
- Insulin Resistance and Apolipoprotein-E Genetype in Alzheimer's Disease (1999) (0)
- Intranasal Insulin- And Biomarker-associated Improvement in Memory and Functional Status in Mild Cognitive Impairment and Alzheimer's Disease: Results of a Randomized, Double-blind, Placebo-controlled Pilot Trial (2010) (0)
- Modulating dietary fat and glycemic load affects CSF biomarkers and cognition in adults with MCI: The role of the Western diet in the pathophysiology of Alzheimer's disease (2010) (0)
- CHANGES IN RETINAL SIGNS AND THEIR ASSOCIATIONS WITH COGNITIVE PERFORMANCE: THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) (2016) (0)
- White Matter Fractional Anisotropy in a Nonhuman Primate Model of Early Alzheimer’s Disease‐like Neuropathology: Relationships with Social Status and Physiologic Measures of Stress Responses (2022) (0)
- S5-01-04: Insulin and Alzheimer's disease therapeutics (2008) (0)
- P1-236 Poor lung function increases the risk of dementia in older adults (2006) (0)
- The Relationship between Vascular Risk Factors and White Matter Structural and Vascular Imaging Metrics (2022) (0)
- Cost consequence analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2). (2023) (0)
- P2-369 Agraphic changes in mild cognitive impairment (2004) (0)
- Targeted microRNA characterization in various brain cell‐derived exosome subtypes to identify novel biomarkers for Alzheimer’s disease (2021) (0)
- Cognitive Neuroendocrinology: New Approaches to the Study of Alzheimer’s Disease and Other Memory Disorders (2001) (0)
- KETOGENIC DIETARY EFFECTS ON SLEEP, COGNITION AND BEHAVIOR IN MCI (2019) (0)
- P-184 APOE-e4 carriers treated with statins have greater insulin-mediated glucose disposal (2007) (0)
- Intranasal insulin may improve brain function in MCI and AD (2018) (0)
- PLASMA AMYLIN LEVELS ARE ASSOCIATED WITH BRAIN STRUCTURE AMONG INDIVIDUALS WITH TYPE-2 DIABETES (2014) (0)
- The Relationship between Vascular Risk Factors and White Matter Structural and Vascular Imaging Metrics (2022) (0)
- Review Article Insulin resistance and pathological brain ageing (2011) (0)
- 1268-P: Associations between ß-Cell Function and Cognitive Measures following Treatment in Youth with Impaired Glucose Tolerance (IGT) or Recently Diagnosed Type 2 Diabetes (T2D) (2020) (0)
- Distinctive age‐related longitudinal dementia progression patterns using a machine‐learning‐based MRI biomarker (2022) (0)
- mRNA‐Binding Protein DJ‐1 as a pivotal protein in AD pathology (2021) (0)
- Aerobic vs. Resistance Training in Older African Americans with Prediabetes: A Pilot Feasibility (2015) (0)
- Effects of Alzheimer’s Disease Risk Factors on Cerebrovascular Dynamics in Gray Matter (2022) (0)
- Interactions of diabetes and postmenopausal hormone therapy on brain volumes: Whims (2015) (0)
- Hippocampal neurogenesis is increased in stroke prone spontaneously hypertensive rats (2010) (0)
- Mild behavioral impairment is associated with sleep apnea, insomnia and brain white matter hyperintensity burden (2022) (0)
- RELATIVE IMPACT OF SAMPLE SIZE AND DIMENSIONALITY OF PREDICTORS ON TWO MACHINE LEARNING METHODS FOR DETECTION OF ALZHEIMER'S DISEASE (2014) (0)
- ALGORITHMIC IDENTIFICATION OF COGNITIVE IMPAIRMENT USING THE UDSV3 BATTERY (2019) (0)
- Impaired glucose tolerance in Mild Cognitive Impairment is associated with lower brain amyloid on PET (2022) (0)
- RELATIONSHIP BETWEEN COGNITIVE AND PHYSICAL FUNCTION IN OLDER ADULTS ACROSS MULTIPLE STUDIES: A POOLED ANALYSIS (2019) (0)
- Comprar Diabetes, Insulin and Alzheimer's Disease | Craft, Suzanne | 9783642042997 | Springer (2010) (0)
- Neuroimaging and clinical characteristics of cognitive migration in community-dwelling older adults (2021) (0)
- Age and cognitive diagnosis influence cerebrospinal fluid ketone levels after a triglyceride infusion in older adults (2020) (0)
- P3-051 Improved detection of plasma beta-amyloid by sandwhich elisa (2004) (0)
- EFFECTS OF DIETARY SATURATED FATS AND SIMPLE CARBOHYDRATES ON CEREBRAL PERFUSION: A RANDOMIZED TRIAL (2017) (0)
- Corrigendum: Relationship between cerebrovascular reactivity and cognition among people with risk of cognitive decline (2022) (0)
- P4-285 Insulin degrading enzyme immunostaining is decreased in the hippocampus of familial Alzheimer's disease subjects with presenilin 1 mutations (2004) (0)
- Binding Parameters of [11C]MPC-6827, a Microtubule-Imaging PET Radiopharmaceutical in Rodents (2023) (0)
- Glucose Metabolism and Memory: Links to Hippocampus (2002) (0)
- Association of instrumental activities of daily living with MCI diagnosis in a large, older, community-based population (2012) (0)
- Scientific Advising and Reviewing: On strengthening the bond between the Alzheimer's Association and the scientific community (2020) (0)
- P3-098 Proteomic analysis of amyloid beta binding proteins in human plasma (2006) (0)
- Cerebrospinal Fluid Metabolomics: Pilot Study of Using Metabolomics to Assess Diet and Metabolic Interventions in Alzheimer’s Disease and Mild Cognitive Impairment (2023) (0)
- LIPIDOMIC PROFILE OF HUMAN CEREBROSPINAL FLUID AFTER AN INTRAVENOUS TRIGLYCERIDE INFUSION (2019) (0)
- Cerebrospinal fluid insulin concentration increases and correlates with memory improvements after intranasal insulin administration (2020) (0)
- P4-034: Seattle adult changes in thought (ACT) study: A population-based “living laboratory” to study dementia and aging (2008) (0)
- Objective sleep hypoxia measures are associated with subjective quality of life ratings in amnestic MCI subjects (2021) (0)
- Comparison of Montreal Cognitive Assessment (MoCA) and 3MSE scores in African-Americans (2013) (0)
- 289 Hyperinsulinemia improves memory in Alzheimer's disease (1996) (0)
- P-123: Establishing reliable screening methods for MCI in a community-based cohort (2007) (0)
- Mediterranean versus western diet effects on cerebral cortical thickness and volume in cynomolgus macaques (2020) (0)
- Improved PET Detection of Focal Brain Activity Using Subset-dependent Relaxation `Dynamic' Row-action Maximum Likelihood Algorithm (DRAMA) (2006) (0)
- Lower cortical thickness is associated with reduced gray matter cerebral blood flow across the AD continuum (2020) (0)
- Blood pressure moderates insulin-induced memory facilitation in older adults with and without memory impairments (2010) (0)
- Insensitivity to dexamethasone-induced declarative memory deficits in patients with schizophrenia (1993) (0)
- Ethanol and cocaine increases microtubule stability and decreases [11C]MPC-6827 uptake in SH-SY5Y cells (2021) (0)
- MARKERS OF INFLAMMATION AND VASCULAR DYSFUNCTION ARE DIFFERENTIALLY ASSOCIATED WITH HIPPOCAMPAL VOLUME BY COGNITIVE STATUS IN ADNI (2014) (0)
- Generalized q‐sampling imaging‐based fiber tracking measures of white matter tracts in cognitive impairment (2022) (0)
- Therapeutic effects of intranasal insulin in patients with AD and amnestic MCI (2005) (0)
- Levels of Soluble Interleukin 6 Receptor and Asp358Ala Are Associated With Cognitive Performance and Alzheimer Disease Biomarkers (2023) (0)
- Subjective cognitive impairment differs by racial/ethnic groups and sociodemographic factors: The Multi‐Ethnic Study of Atherosclerosis and Alzheimer’s Disease (MESA‐MIND) (2020) (0)
- Influence of diet macronutrients on cognition and the interaction with ApoE ɛ4 genotype (2012) (0)
- Cognitive effects of estrogen in women with Alzheimer's disease (1999) (0)
- Neuroendocrine markers of cognition-enhancing efficacy of estrogen in postmenopausal women with Alzheimer's disease (2000) (0)
- P1-394 Increased plasma retinol binding protein 4 levels in insulin-resistant adults with Alzheimer’s disease (2006) (0)
- Care management for VA patients with vascular risk factors and cognitive impairment: A randomized trial (2013) (0)
- Diets associated with type 2 diabetes and insulin resistance affect CSF mediators of Beta-amyloid clearance and toxicity (2011) (0)
- MARKERS OF INFLAMMATION AND VASCULAR DYSFUNCTION ARE DIFFERENTIALLY ASSOCIATED WITH HIPPOCAMPAL VOLUME BY COGNITIVE STATUS IN ADNI (2014) (0)
- P2-397 Safety and tolerability of rosiglitazone (RSG) in patients with mild to moderate Alzheimer’s disease (AD) (2006) (0)
- Ketogenic Diet Improves Gut Microbiome and Alzheimer's Disease Markers (FS09-02-19) (2019) (0)
- Systemic Bioenergetic Capacity Changes with Cognitive Status and Insulin Sensitivity in Older Adults (2021) (0)
- Aberrant DJ-1 expression underlies L-type calcium channel hypoactivity in tuberous sclerosis complex and Alzheimer’s disease (2020) (0)
- P-027 CSF transthyretin levels are associated with APOE genotype and CSF aβ42 in AD (2007) (0)
- ABNORMAL DJ-1 EXPRESSION IN ALZHEIMER'S DISEASE AND ITS IMPACT ON SYNAPTIC MRNA TRANSLATION AND FUNCTION (2019) (0)
- Parametric cerebral blood flow and arterial transit time mapping using a 3D convolutional neural network. (2023) (0)
- APOE ε4 ALLELE EFFECT ON WHITE AND GRAY MATTER PERFUSION IN COGNITIVELY NORMAL AND MCI GROUPS (2017) (0)
- Utilizing study and site performance metrics to improve efficiency of clinical trials: An initiative of the Alzheimer’s Clinical Trials Consortium (ACTC) (2021) (0)
- Subclinical Vascular Composites Predict Clinical Cardiovascular Disease, Stroke, and Dementia: The Multi-Ethnic Study of Atherosclerosis (MESA). (2023) (0)
- Age‐related association between white matter integrity and cerebral blood flow in white matter (2021) (0)
- Investigating predictors of incident cognitive impairment in women (2021) (0)
- P2-352 Alzheimer's disease: potential beneficial effects of estrogen on performance-based battery of physical function skills for older women (2004) (0)
- Cortical gray matter volume and working memory in a NHP model of AD‐like neuropathology (2021) (0)
- Abstract WP562: Retinal Vessel Caliber is Associated With Cognitive Function Independent of Cerebrovascular and Renal Disease: The Multi-Ethnic Study of Atherosclerosis (MESA) (2019) (0)
- MODIFIDED KETOGENIC DIET IS ASSOCIATED WITH IMPROVED CSF BIOMARKER PROFILE, CEREBRAL PERFUSION, AND CEREBRAL KETONE BODY UPTAKE IN OLDER ADULTS AT-RISK FOR ALZHEIMER’S DISEASE: A PILOT STUDY (2019) (0)
- Distinctive age‐related longitudinal dementia progression patterns using a machine‐learning‐based MRI biomarker (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Suzanne Craft?
Suzanne Craft is affiliated with the following schools:
